Exponent (EXPO) Projected to Announce Quarterly Earnings on Thursday

Exponent (NASDAQ:EXPO) is expected to be announcing its Q4 2025 results after the market closes on Thursday, February 5th. Analysts expect the company to announce earnings of $0.47 per share and revenue of $128.48 million for the quarter. Interested persons may visit the the company’s upcoming Q4 2025 earning results page for the latest details on the call scheduled for Thursday, February 5, 2026 at 4:30 PM ET.

Exponent (NASDAQ:EXPO) last released its quarterly earnings results on Thursday, October 30th. The business services provider reported $0.55 earnings per share for the quarter, beating analysts’ consensus estimates of $0.50 by $0.05. Exponent had a net margin of 18.35% and a return on equity of 24.77%. The business had revenue of $147.12 million for the quarter, compared to the consensus estimate of $131.78 million. During the same quarter last year, the firm earned $0.50 EPS. Exponent’s revenue for the quarter was up 9.6% on a year-over-year basis. On average, analysts expect Exponent to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Exponent Stock Performance

NASDAQ EXPO opened at $73.49 on Thursday. Exponent has a twelve month low of $63.81 and a twelve month high of $97.57. The stock has a market capitalization of $3.67 billion, a PE ratio of 35.85 and a beta of 0.81. The stock has a 50-day simple moving average of $72.84 and a 200 day simple moving average of $70.99.

Exponent announced that its board has authorized a share buyback plan on Thursday, October 30th that allows the company to repurchase $100.00 million in outstanding shares. This repurchase authorization allows the business services provider to buy up to 3% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company’s leadership believes its stock is undervalued.

Wall Street Analyst Weigh In

EXPO has been the subject of a number of research reports. William Blair raised shares of Exponent from a “market perform” rating to an “outperform” rating in a report on Monday, November 17th. Weiss Ratings restated a “hold (c-)” rating on shares of Exponent in a report on Thursday, January 22nd. JPMorgan Chase & Co. assumed coverage on shares of Exponent in a research report on Monday. They set an “overweight” rating and a $100.00 price objective for the company. Finally, UBS Group restated a “neutral” rating and set a $81.00 price objective (up previously from $76.00) on shares of Exponent in a research note on Monday, December 15th. Two analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $90.50.

Insider Buying and Selling at Exponent

In other Exponent news, CEO Catherine Corrigan sold 4,900 shares of the firm’s stock in a transaction on Monday, November 17th. The stock was sold at an average price of $70.39, for a total transaction of $344,911.00. Following the transaction, the chief executive officer directly owned 83,429 shares in the company, valued at approximately $5,872,567.31. This trade represents a 5.55% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders sold a total of 9,788 shares of company stock valued at $693,648 in the last 90 days. 1.60% of the stock is owned by company insiders.

Hedge Funds Weigh In On Exponent

Several institutional investors have recently bought and sold shares of the company. CIBC Bancorp USA Inc. purchased a new position in Exponent in the 3rd quarter valued at approximately $377,000. Voleon Capital Management LP boosted its stake in shares of Exponent by 428.9% in the 3rd quarter. Voleon Capital Management LP now owns 59,689 shares of the business services provider’s stock valued at $4,147,000 after purchasing an additional 48,404 shares in the last quarter. Voloridge Investment Management LLC boosted its holdings in Exponent by 44.2% during the 3rd quarter. Voloridge Investment Management LLC now owns 255,147 shares of the business services provider’s stock valued at $17,728,000 after acquiring an additional 78,237 shares during the period. Verition Fund Management LLC boosted its position in Exponent by 325.4% during the 3rd quarter. Verition Fund Management LLC now owns 44,100 shares of the business services provider’s stock valued at $3,064,000 after buying an additional 33,734 shares during the period. Finally, Northern Trust Corp increased its holdings in Exponent by 0.6% during the 3rd quarter. Northern Trust Corp now owns 733,354 shares of the business services provider’s stock valued at $50,953,000 after purchasing an additional 4,695 shares during the period. Hedge funds and other institutional investors own 92.37% of the company’s stock.

Exponent Company Profile

Exponent, Inc (NASDAQ: EXPO) is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company’s expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.

Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.